...
【24h】

Determinants of Blood Uric Acid Levels in a Dyslipidemic Arab Population

机译:血脂异常阿拉伯人群中血尿酸水平的决定因素

获取原文
           

摘要

Objectives: The objective of this study was to explore the relationships between circulating uric acid and lipid levels and components of the metabolic syndrome (MetS) in Arab dyslipidemic patients, a group already at high coronary artery disease risk. Subjects and Methods: The medical records of 1,229 subjects (632 men, 597 women) referred for treatment of dyslipidemia and followed up for at least 12 months were reviewed. Serum levels of uric acid and lipids (total cholesterol, triglycerides, low-density lipoprotein, high-density lipoprotein) and other variables in the National Cholesterol Education Program ATP III criteria definition of MetS were assessed at initial presentation and every 4– 6 months, under specific lipid-lowering treatment (statins and/or fibrates), in each of the subjects. Their respective associations were explored by appropriate logistic regression techniques with control for confounding risk factors, including age, gender and body mass index. Results: 306 subjects (24.9%) of the study population were hyperuricemic; they were more likely to be men, obese and diabetic. Also the serum uric acid level (mean ± SD) was greater in men with MetS compared with men without (377.0 ± 98.0 vs. 361.6 ± 83.1 μmol/l, p Conclusion: The data showed that hyperuricemia is common in dyslipidemic patients in Kuwait, where its important determinants are male sex, obesity, diabetes and statin treatment.
机译:目的:本研究的目的是探讨阿拉伯血脂异常患者的循环尿酸水平与血脂水平和代谢综合征(MetS)成分之间的关​​系,该人群已经具有较高的冠心病风险。受试者和方法:回顾了接受血脂异常治疗并至少随访12个月的1,229名受试者(632名男性,597名女性)的病历。美国国家胆固醇教育计划ATP III标准定义的MetS的血清尿酸和脂质(总胆固醇,甘油三酸酯,低密度脂蛋白,高密度脂蛋白)和其他变量的水平在首次出现时和每4-6个月进行评估,在每个受试者中进行特定的降脂治疗(他汀类药物和/或贝特类药物)。通过适当的逻辑回归技术并控制混杂因素,包括年龄,性别和体重指数,探索了它们各自的关联。结果:研究人群中有306名受试者(占24.9%)患有高尿酸血症。他们更有可能是男性,肥胖和糖尿病。同样,患有MetS的男性患者的血清尿酸水平(平均值±SD)高于未患有MetS的男性(377.0±98.0 vs. 361.6±83.1μmol/ l,p)结论:数据表明,科威特血脂异常患者常见高尿酸血症,其重要决定因素是男性,肥胖症,糖尿病和他汀类药物的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号